Skip to main content
. 2019 Dec 28;13(2):346–354. doi: 10.1016/j.tranon.2019.10.016

Table 2.

Associations Between Clinicopathological Parameters and the Mutational Status of Several Genes.

EGFR
IDH1/2
NF1
PTEN
TERT
TP53
wt mut p wt Mut p wt mut p wt mut p wt mut p wt mut p
Age Median (minimum–maximum) 54.6 (21.3–77.9) 59.0 (40.8–78.2) 0.209 56.2 (21.3–78.2) 43.2 (25.2–62.9) 0.001 54.4 (21.3–78.2) 62.7 (45.9–73.8) 0.064 54.5 (21.3–78.2) 57.1 (53.4–65.7) 0.423 46.5 (21.3–74.1) 57.7 (33.0–78.2) <0.001 54.6 (23.1–78.2) 59.0 (21.3–77.9) 0.805
Ki67 Median (minimum–maximum) 17.0 (0–80.0) 25.0 (0.5–70.0) 0.538 18.0 (0–70.0) 15.0 (1.5–80.0) 0.961 18.0 (0–80.0) 16.0 (3.0–20.0) 0.279 18.0 (0–80.0) 25.0 (8.0–35.0) 0.675 16.5 (0–75.0) 18 (0–80.0) 0.802 18.0 (0–70.0) 18.0 (0–80.0) 0.984
Tumor grade III 15 (17.4) 1 (6.7) 0.292 6 (6.9) 10 (71.4) <0.001 16 (17.0) 0 (0.0) 0.234 16 (16.8) 0 (0.0) 0.273 7(26.9) 9(12.0) 0.073 8 (10.5) 8 (32.0) 0.011
IV 71 (82.6) 14 (93.3) 81 (93.1) 4 (28.6) 78 (83.0) 7 (100.0) 79 (83.2) 6 (100.0) 19(73.1) 66(88.0) 68 (89.5) 17 (68.0)
Sex Female 33 (38.4) 9 (60.0) 0.117 38 (43.7) 4 (28.6) 0.287 40 (42.6) 2 (28.6) 0.469 38 (40.0) 4 (66.7) 0.199 9(34.6) 33(44.0) 0.403 29 (38.2) 13 (52.0) 0.223
Male 53 (61.6) 6 (40.0) 49 (56.3) 10 (71.4) 54 (57.4) 5 (71.4) 57 (60.0) 2 (33.3) 17(65.4) 42(56.0) 47 (61.8) 12 (48.0)
Type of surgery Biopsy/stereotactic biopsy 19 (23.2) 4 (28.6) 0.892 18 (21.7) 5 (38.5) 0.368 21 (23.6) 2 (28.6) 0.553 20 (22.2) 3 (50.0) 0.256 9(36.0) 14(19.7) 0.119 18 (25.0) 5 (20.8) 0.835
Subtotal 52 (63.4) 8 (57.1) 54 (65.1) 6 (46.2) 55 (61.8) 5 (71.4) 58 (64.4) 2 (33.3) 15(60.0) 45(63.4) 45 (62.5) 15 (62.5)
Total excision 11 (13.4) 2 (14.3) 11 (13.3) 2 (15.4) 13 (14.6) 0 (0.0) 12 (13.3) 1 (16.7) 1(4.0) 12(16.9) 9 (12.5) 4 (16.7)
Necrosis No 18 (20.9) 1 (6.7) 0.192 10 (11.5) 9 (64.3) <0.001 19 (20.2) 0 (0.0) 0.187 19 (20.0) 0 (0.0) 0.224 9(34.6) 10(13.3) 0.017 12 (15.8) 7 (28.0) 0.175
Yes 68 (79.1) 14 (93.3) 77 (88.5) 5 (35.7) 75 (79.8) 7 (100.0) 76 (80.0) 6 (100.0) 17(65.4) 65(86.7) 64 (84.2) 18 (72.0)
Hemorrhage No 20 (23.3) 3 (20.0) 0.781 15 (17.2) 8 (57.1) 0.001 22 (23.4) 1 (14.3) 0.579 22 (23.2) 1 (16.7) 0.713 11(42.3) 12(16.0) 0.006 13 (17.1) 10 (40.0) 0.018
Yes 66 (76.7) 12 (80.0) 72 (82.8) 6 (42.9) 72 (76.6) 6 (85.7) 73 (76.8) 5 (83.3) 15(57.7) 63(84.0) 63 (82.9) 15 (60.0)
Endothelial hyperplasia No 17 (19.8) 1 (6.7) 0.221 10 (11.5) 8 (57.1) <0.001 18 (19.1) 0 (0.0) 0.202 18 (18.9) 0 (0.0) 0.240 6(23.1) 12(16.0) 0.417 13 (17.1) 5 (20.0) 0.743
Yes 69 (80.2) 14 (93.3) 77 (88.5) 6 (42.9) 76 (80.9) 7 (100.0) 77 (81.1) 6 (100.0) 20(76.9) 63(84.0) 63 (82.9) 20 (80.0)

wt: wild-type; mut: mutated. P-values in bold indicate statistically significant results at the 5% level of significance.